Michael R. Minogue - Sep 30, 2021 Form 4 Insider Report for ABIOMED INC (ABMD)

Role: Chairman, President, CEO, Director
Signature: /s/ Marc A Began (by power of attorney)
Stock symbol: ABMD
Transactions as of: Sep 30, 2021
Transactions value $: $0
Form type: 4
Date filed: 10/4/2021, 05:19 PM
Previous filing: Aug 25, 2021
Next filing: Nov 5, 2021

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ABMD	Common Stock $.01 par value	Award	$0	+36	+0.02%	$0.00	212K	Sep 30, 2021	Direct	F4
holding	ABMD	Common Stock $.01 par value						52.6K	Sep 30, 2021	By Trust - A
holding	ABMD	Common Stock $.01 par value						73.7K	Sep 30, 2021	By Trust - B
holding	ABMD	Common Stock $.01 par value						32.8K	Sep 30, 2021	By Trust - C
holding	ABMD	Common Stock $.01 par value						655	Sep 30, 2021	By Trust - D
holding	ABMD	Common Stock $.01 par value						38.6K	Sep 30, 2021	By Trust - E
holding	ABMD	Common Stock $.01 par value						85K	Sep 30, 2021	By Trust - F

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	ABMD	Stock Option (right to buy)						85K	Sep 30, 2021	Common Stock	0	$21.55	Direct	F1, F2
holding	ABMD	Stock Option (right to buy)						35K	Sep 30, 2021	Common Stock	0	$66.25	Direct	F1, F2
holding	ABMD	Stock Option (right to buy)						30.5K	Sep 30, 2021	Common Stock	0	$99.62	Direct	F2, F3
holding	ABMD	Stock Option (right to buy)						33K	Sep 30, 2021	Common Stock	0	$134.51	Direct	F2, F3
holding	ABMD	Stock Option (right to buy)						30K	Sep 30, 2021	Common Stock	0	$381.97	Direct	F2, F3
holding	ABMD	Stock Option (right to buy)						50K	Sep 30, 2021	Common Stock	0	$266.39	Direct	F2, F3
holding	ABMD	Stock Option (Right to Buy)						20.9K	Sep 30, 2021	Common Stock	0	$223.90	Direct	F2, F3
holding	ABMD	Stock Option (Right to Buy)						30K	Sep 30, 2021	Common Stock	0	$283.88	Direct	F2, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Grant to reporting person of option to buy the number of shares of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 2008 Stock Incentive Plan.
F2	These options become exercisable in annual 33-1/3% increments, commencing on the date shown in Table II, Column 6.
F3	Grant to reporting person of option to buy the number of shares of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 2015 Omnibus Incentive Plan.
F4	These shares of common stock were acquired by the reporting person through participation in the ABIOMED, Inc. Employee Stock Purchase Plan, qualified under Section 423 of the Internal Revenue Code, and the transaction was exempt under Rule 16b-3(c).